<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16728">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02027909</url>
  </required_header>
  <id_info>
    <org_study_id>CRIPS</org_study_id>
    <nct_id>NCT02027909</nct_id>
  </id_info>
  <brief_title>A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction</brief_title>
  <acronym>CRIPS</acronym>
  <official_title>A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arun Rao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Wellmont CVA Heart Institute</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Providing ideal rate response to patients should improve their quality of life and ability
      to execute activities of daily living.

      Medtronic pacemakers provide rate response pacing by utilizing dual zone programming to
      specify an &quot;activities of daily living&quot; (ADL) response rate and an &quot;exertion&quot; response rate.
        There is much data to support the target heart rate for an exercise response but the data
      to support the programming of the ADL rate is lacking.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Medtronic pacemakers provide rate response pacing by utilizing dual zone programming to
      specify an &quot;activities of daily living&quot; (ADL) response rate and an &quot;exertion&quot; response rate.
        There is much data to support the target heart rate for an exercise response but the data
      to support the programming of the ADL rate is lacking.

      Unpublished Holter data from our center indicates that the ADL rate for most patients in our
      practice is between 50-70bpm rather than 95bpm.  Moreover, this increased ADL rate may
      impact diastolic filling times and adversely impact cardiac output.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>symptom improvement</measure>
    <time_frame>study duration of 9 mths</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient report symptoms by clinician interview and patient symptom questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>improvement seen on device interrogations and reported improvement of symptoms</measure>
    <time_frame>study duration of 9 mths</time_frame>
    <safety_issue>No</safety_issue>
    <description>Two minute hall walk distance Heart rate histograms and sensor indicated rate profile obtained from device interrogation Patient reported symptoms Patient symptom questionnaire Quality of life as measured by SF-36</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">21</enrollment>
  <condition>Sinus Node Dysfunction</condition>
  <arm_group>
    <arm_group_label>Therapy group one</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lower rate of 60 bpm and out of the box rate response settings of an ADL Rate of 95 bpm and rate profile optimization on with the only change being adjusting the activity threshold from med/low to low.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapy group two</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Rate response programming will be determined by an exercise test consisting of a 2 minute hall walk will be performed at the 2 week follow up and set points will be manually adjusted to achieve an ADL rate of 95 bpm.  Rate Profile Optimization will be turned off. Activity threshold is programmed to low.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapy group three</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lower rate of 60 bpm and the ADL rate based upon 220- age x 55%.  Activity threshold is programmed to low.  Rate Profile Optimization will be turned ON.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Reprogramming dual chamber pacemaker</intervention_name>
    <description>Reprogramming rate response feature in the Medtronic pacemaker to each arm with crossover</description>
    <arm_group_label>Therapy group one</arm_group_label>
    <arm_group_label>Therapy group two</arm_group_label>
    <arm_group_label>Therapy group three</arm_group_label>
    <other_name>Medtronic dual chamber pacemaker</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of hypertension

          -  Sinus node dysfunction

          -  New implantation of a dual chamber pacemaker due to symptomatic sinus dysfunction or
             chronotropic incompetence defined as exercise heart rate less than 100 beats per
             minute

        Exclusion Criteria:

          -  Second or Third degree AV block

          -  Age less than 60 or greater than 95 years

          -  EF less than 45%

          -  Patients that are not ambulatory

          -  Persistent atrial fibrillation (atrial fibrillation lasting greater than 7 days)

          -  Permanent atrial fibrillation (atrial fibrillation lasting great than 1 year)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arun Rao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wellmont CVA Heart Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ashley Sparks, LPN</last_name>
    <phone>423-230-5062</phone>
    <email>asparks@mycva.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Terrie Walker, BSN</last_name>
    <phone>423-230-5643</phone>
    <email>twalker@mycva.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wellmont CVA Heart Institute</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Sparks, LPN</last_name>
      <phone>423-230-5062</phone>
      <email>asparks@mycva.com</email>
    </contact>
    <contact_backup>
      <last_name>Terrie Walker, BSN</last_name>
      <phone>423-230-5643</phone>
      <email>twalker@mycva.com</email>
    </contact_backup>
    <investigator>
      <last_name>Arun Rao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lau CP, Leung SK. Clinical usefulness of rate adaptive pacing systems: what should we assess? Pacing Clin Electrophysiol. 1994 Dec;17(12 Pt 1):2233-5.</citation>
    <PMID>7885929</PMID>
  </reference>
  <reference>
    <citation>Rate adaptive pacing in sick sinus syndrome: Effects of pacing modes. Lau ,C et al. European heart Journal (1994)15:1445-1455.</citation>
  </reference>
  <reference>
    <citation>Oto MA, MÃ¼derrisoglu H, Ozin MB, Korkmaz ME, Karamehmetoglu A, Oram A, Oram E, Ugurlu S. Quality of life in patients with rate responsive pacemakers: a randomized, cross-over study. Pacing Clin Electrophysiol. 1991 May;14(5 Pt 1):800-6.</citation>
    <PMID>1712957</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 2, 2014</lastchanged_date>
  <firstreceived_date>December 31, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Wellmont CVA Heart Institute</investigator_affiliation>
    <investigator_full_name>Arun Rao</investigator_full_name>
    <investigator_title>Arun Rao, MD. FACC</investigator_title>
  </responsible_party>
  <keyword>Sinus Node Dysfunction</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sick Sinus Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
